# Predicting Obesity Consequences Using Body Measure and Urine Metabolomics

> **NCT04989062** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 1200 (estimated)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Body Composition
- Electric Impedance

## Interventions

- **DIAGNOSTIC_TEST:** Fibroscan
- **DIAGNOSTIC_TEST:** Bioelectrical impedance analysis
- **DIAGNOSTIC_TEST:** Urine unclear magnetic resonance metabolomics
- **DIAGNOSTIC_TEST:** Hand grip strength

## Key facts

- **NCT ID:** NCT04989062
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2021-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989062, "Predicting Obesity Consequences Using Body Measure and Urine Metabolomics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04989062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*